Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis
Lab / animal
OA: bronze
CC0
⤵ 77 in-corpus citations
AI-generated summary
1,25-dihydroxy vitamin D3 suppressed inflammation and proliferation in human endometriotic stromal cells, and lower serum vitamin D levels were associated with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
CONTEXT: Endometriosis is an estrogen-dependent, chronic inflammatory disease. Recent studies have shown that vitamin D (VD) is an effective modulator of the immune system and plays an important role in controlling many inflammatory diseases.
OBJECTIVE: The objective of the study was to clarify the in vitro effects of 1,25-dihydroxy vitamin D3 (1,25[OH]2D3) on human endometriotic stromal cells (ESCs) and to determine the serum levels of VD in endometriosis patients.
DESIGN, PATIENTS, AND MAIN OUTCOME MEASURES: ESCs were isolated from ovarian endometrioma and cultured with 1,25(OH)2D3. Gene expression of IL-8, cyclooxygenase-2, microsomal prostaglandin E synthase-1, microsomal prostaglandin E synthase-2, cytosolic prostaglandin E synthase, 15-hydroxyprostaglandin dehydrogenase, matrix metalloproteinase (MMP)-2, and MMP-9 was examined using quantitative RT-PCR. The production of IL-8 and prostaglandin E2 was measured using an ELISA and an enzyme immunoassay. Viable cell number was assessed using a cell-counting assay, and DNA synthesis was assessed using the bromodeoxyuridine incorporation assay. Apoptosis was assessed using flow cytometry. The expression of inhibitory-κBα protein was detected using Western blotting. The serum levels of 25-hydroxyvitamin D3 and 1,25(OH)2D3 were measured by a RIA.
RESULTS: In vitro studies showed that 1,25(OH)2D3 significantly reduced IL-1β- or TNF-α-induced inflammatory responses, such as IL-8 expression and prostaglandin activity. 1,25(OH)2D3 also reduced viable ESC numbers and DNA synthesis but did not affect apoptosis. MMP-2 and MMP-9 expressions were reduced by 1,25(OH)2D3. 1,25(OH)2D3 inhibited nuclear factor-κB activation. The serum 25-hydroxyvitamin D3 levels were significantly lower in women with severe endometriosis than in the controls and women with mild endometriosis. Serum 1,25(OH)2D3 levels were not different between groups.
CONCLUSIONS: VD modulates inflammation and proliferation in endometriotic cells, and a lower VD status is associated with endometriosis. Taken together, VD supplementation could be a novel therapeutic strategy for managing endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (48)
- 1-alpha,25-dihydroxyvitamin D3 regresses endometriotic implants in rats by inhibiting neovascularization and altering regulation of matrix metalloproteinase via openalex
- Activin-A is induced by interleukin-1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2 and proliferation of stromal cells from endometrioma via openalex
- Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis via openalex
- IL-1β increases expression of tryptophan 2,3-dioxygenase and stimulates tryptophan catabolism in endometrioma stromal cells via openalex
- Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis via openalex
- Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers via openalex
- The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation via openalex
- Vitamin D metabolites--relation to age, menopause and endometriosis via openalex
- W2036186003 via openalex
- W2037841968 via openalex
- W2038177382 via openalex
- W2049619918 via openalex
- W2062528888 via openalex
- W2068262580 via openalex
- W2076496958 via openalex
- W2096298138 via openalex
- W2098790474 via openalex
- W2101213151 via openalex
- W2112032088 via openalex
- W2116263654 via openalex
- W1541134664 via openalex
- W2124070987 via openalex
- W2151576515 via openalex
- W2154544186 via openalex
- W2157243060 via openalex
- W2157568141 via openalex
- W2161276145 via openalex
- W2281471315 via openalex
- W4211081176 via openalex
- W6647640596 via openalex
- W6695612392 via openalex
- W6814680148 via openalex
- W2117226827 via openalex
- W1548811205 via openalex
- W1915029264 via openalex
- W1967552317 via openalex
- W1989670144 via openalex
- W1991673163 via openalex
- W2000106377 via openalex
- W2003776922 via openalex
- W2005033425 via openalex
- W2005692454 via openalex
- W2020953198 via openalex
- W2031012830 via openalex
Cited by (50)
- The Role of Dietary Supplements in the Treatment of Endometriosis: A Critical Review 2026
- THE IMPACT OF SELECTED DIETS AND NUTRIENTS ON THE DEVELOPMENT AND PROGRESSION OF ENDOMETRIOSIS: A LITERATURE REVIEW 2026
- Vitamin D in Reproductive Health Disorders: A Narrative Review Focusing on Infertility, Endometriosis, and Polycystic Ovarian Syndrome 2025
- Vitamin D Levels in Patients with Endometriosis Cysts 2025
- How Can Selected Dietary Ingredients Influence the Development and Progression of Endometriosis? 2024
- The effects of oral nutritional supplements on endometriosis-related pain: A narrative review of clinical studies 2024
- The Supplemental Effect of Vitamin-D3 and Omega-3 on Induced Endometriosis in Rat Model to Investigate the Inflammatory Response 2024
- Association between vitamin D and endometriosis among American women: National Health and Nutrition Examination Survey 2024
- Schmerztherapie bei Patientinnen mit Endometriose 2024
- Nutritional interventions in the management of endometriosis – review of the literature 2024
- Does diet influence the development and treatment of endometriosis? - A literature review 2024
- Vitamin D-The Iceberg in Endometriosis-Review and Meta-Analysis 2024
- Serum Vitamin D Levels, Visual Analog Scale Dysmenorrhea Score, and Endometriosis ASRM Classification: a Relationship Study 2024
- Indian Medicinal Plants for the Management of Endometriosis: A Comprehensive Review on their phytopharmacology 2023
- Nuclear Expression of Phosphohistone H3 and Vitamin D Receptor – New Potential Markers in Diagnosis and Treatment of Endometriosis 2023
- Potential impact of vitamin D on women’s reproductive health 2023
- Endometriosis Therapy: Not Only Hormones and Surgery - The Importance of a Holistic Approach 2023
- (no title) 2023
- Vitamin D and Mitosis Evaluation in Endometriosis: A Step toward Discovering the Connection? 2023
- Schmerztherapie bei Patientinnen mit Endometriose 2023
- [Holistic treatment of endometriosis] 2023
- Additional file 2 of Effects of vitamin D supplementation in endometriosis: a systematic review 2023
- Additional file 4 of Effects of vitamin D supplementation in endometriosis: a systematic review 2023
- Additional file 1 of Effects of vitamin D supplementation in endometriosis: a systematic review 2023
- Additional file 3 of Effects of vitamin D supplementation in endometriosis: a systematic review 2023
- 25(OH)D3 improves granulosa cell proliferation and IVF pregnancy outcomes in patients with endometriosis by increasing G2M+S phase cells 2023
- Vitamin D inhibited endometriosis development in mice model through interleukin-17 modulation 2022
- Effect of active vitamin D on proliferation, cell cycle and apoptosis in endometriotic stromal cells 2022
- Effects of vitamin D supplementation in endometriosis: a systematic review 2022
- Nutritional Interventions, Complementary and Alternative Medicine for Endometriosis 2022
- Endometriosis, an Ongoing Pain-Step-by-Step Treatment 2022
- The Effect of Laparoscopic Radical Surgery for Endometriosis on Serum Levels of Lipid Profile and Vitamin D 2022
- Evaluation of Cholecalciferol Interaction with Pain Signaling after Laparoscopic Ablation of Endometriotic Lesions in Women with Hypovitaminosis D 2022
- A systematic review of vitamin D and endometriosis: role in pathophysiology, diagnosis, treatment, and prevention 2022
- Changes in MCP-1, HGF, and IGF-1 expression in endometrial stromal cells, PBMCs, and PFMCs of endometriotic women following 1,25(OH)2D3 treatment 2022
- Characteristics of Endometriosis Patients in Dr. Mohammad Hoesin General Hospital on 2018 to 2020 2022
- Additional file 1 of Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial 2021
- The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis 2021
- [Management of endometriosis pain : Stage-based treatment strategies and clinical experience] 2021
- Ovarian reserve may influence the outcome of bone mineral density in patients with long-term use of dienogest 2021
- Association between dietary inflammatory index and endometriosis risk in a case-control study 2021
- Auto-immunity and endometriosis 2021
- The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target 2021
- Vitamin D status in endometriosis: a systematic review and meta-analysis 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Vitamin D deficiency as a risk factor for endometriosis in Iranian women 2020
- Niclosamide suppresses macrophage-induced inflammation in endometriosis† 2020
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:17:32.889250+00:00
License: CC0
· commercial use OK